Eptifibatide bulk supplier for pharma manufacturers

Eptifibatide 2 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 2 mg/mL

Reference Brands: Integrilin (USA)

Eptifibatide is a Heart Disorder product available as Injection in strengths 2 mg/mL. It corresponds to the reference brand Integrilin (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Eptifibatide is a potent intravenous antiplatelet agent belonging to the glycoprotein IIb/IIIa inhibitor class, widely used to reduce ischemic cardiac events in high-risk cardiovascular patients. It is FDA-approved for the medical management of unstable angina and non-ST elevation myocardial infarction (NSTEMI), as well as for patients undergoing percutaneous coronary intervention (PCI), including intracoronary stent placement. Clinical evidence from the IMPACT-II trial demonstrated that eptifibatide, when used in combination with heparin and aspirin, significantly reduces ischemic complications following PCI, particularly in patients with unstable angina.

Eptifibatide is marketed under the brand name Integrilin and was developed by Millennium Pharmaceuticals, with co-promotion by Schering-Plough/Essex. Structurally, it is a synthetic cyclic heptapeptide derived from a disintegrin protein originally identified in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). Pharmacologically, it acts as a reversible arginine-glycine-aspartate (RGD) mimetic that inhibits platelet aggregation by blocking fibrinogen binding to activated glycoprotein IIb/IIIa receptors on platelets. Eptifibatide has a rapid onset of action and a short half-life, making it suitable for controlled use in acute cardiac care settings.

Eptifibatide — third party manufacturing & bulk supply

Eptifibatide 2 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Eptifibatide is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Eptifibatide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Eptifibatide →

Back to Listing

Frequently Asked Questions

Eptifibatide is used for the prevention of acute cardiac ischemic complications in patients with acute coronary syndrome and in those undergoing percutaneous coronary intervention, including angioplasty and stent placement.

Eptifibatide is made from eptifibatide acetate, a synthetic cyclic heptapeptide that selectively inhibits the platelet glycoprotein IIb/IIIa receptor.

The primary trade name of eptifibatide is Integrilin.

Integrilin was originally developed and marketed by Millennium Pharmaceuticals (now part of Takeda), while generic versions are manufactured by various pharmaceutical companies globally.

The generic name is eptifibatide acetate.

The brand name is Integrilin.

Eptifibatide is manufactured in several countries, including the USA, EU nations, India, and other regulated pharmaceutical manufacturing regions, depending on the supplier and regulatory approvals.